CD8A and neoplasm: Taken together, these findings suggest that VVL-DD induces a stronger and more sustained immune response, particularly in the tumor microenvironment and lymph nodes, with significant recruitment of CD8+ T-cells and macrophages, critical for antitumor immunity.